1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
OPIOID AND STIMULANT USE DISORDER PREVENTION AND EDUCATION is sponsored by Department of Health Care Services. This program will be supported by the California State Opioid Response (SOR) IV grant program funded by DHCS. This grant was provided to DHCS by the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA).
The SOR IV grant supports the DHCS Opioid Response Project which aims to address the opioid and stimulant use disorder crises by improving access to treatment, reducing unmet treatment needs, and reducing overdose deaths. This funding opportunity will support programs addressing opioid use, stimulant use and polysubstance use in California’s communities, which have been impacted by the opioid and stimulant use disorder crises.
While California has made significant progress in addressing the opioid epidemic, in 2024 there were still 5,462 overdose deaths reported1.
The goals of this funding opportunity are to support awareness, outreach and education addressing opioids and stimulants, as well as polysubstance use, and to strengthen referral pathways to care and treatment services, including Medications for Opioid Use Disorder (MOUD), in all communities across the state.
We invite applications from community-based and nonprofit organizations that have a strong track record of delivering community outreach and education projects.
Get alerted about grants like this
Get emailed when new opportunities from “Department of Health Care Services” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofit. Please see page 5 of RFA for full eligibility requirements. Confirm the full requirements in the official notice before applying.
The current listing shows between $1 and $200,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for OPIOID AND STIMULANT USE DISORDER PREVENTION AND EDUCATION are due July 22, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
OPIOID AND STIMULANT USE DISORDER PREVENTION AND EDUCATION is funded by Department of Health Care Services. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
State Opioid Response (SOR) Grant is sponsored by California Department of Health Care Services (DHCS). The State Opioid Response (SOR) grant aims to increase access to Medication-Assisted Treatment (MAT), reduce unmet treatment needs, and decrease opioid overdose deaths through programs focused on prevention, treatment, and recovery. The California DHCS Opioid Response specifically targets populations with limited MAT access, including youth, rural areas, and American Indian & Alaska Native tribal communities. This is the fourth iteration of the SOR grant.
State Opioid Response (SOR) Grant is sponsored by Substance Abuse and Mental Health Services Administration (SAMHSA) / California Department of Health Care Services (DHCS). The SOR grant focuses on addressing the opioid crisis by supporting prevention, education, stigma reduction, treatment, and recovery services for people with opioid use disorder and substance use disorder, and by increasing access to medication-assisted treatment services. California is in its fourth iteration of the SOR grant.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.
PMHCA (HRSA-26-058) makes $9.79 million available for up to 22 awards of up to $445,000 to build tele-consultation networks that help pediatric primary care providers manage children's behavioral health. The catch buried in the eligibility section: applicants must NOT already hold a PMHCA award — which effectively reserves the new-state lane for the eight unfunded states and territories, plus tribes everywhere. Here's how to read it and what wins.
Read articleThe Elevance Health Foundation's FY2026 Maternal/Infant Health cycle offers grants around $1 million (1–3 years, 15% indirects) to reduce pre-term birth and severe maternal morbidity. But eligibility hinges on a specific 501(c)(3) subsection test, funding concentrates in 10 states plus national scalable programs, and a corporate payer-funder judges you on measurable outcomes, not need. Here is how to read this RFP and compete before the July 31 deadline.
Read articleElevance Health Foundation's maternal/infant health RFP closes July 31, 2026, part of a five-year, $150 million commitment. Last cycle it awarded 29 grants totaling $6.5M across the pregnancy continuum. Here is what the funder actually rewards — measurable disparity reduction, a 15% indirect-cost cap, and scalable models — plus how nonprofits in the 10 priority states should frame a competitive proposal.
Read article